Literature DB >> 10779143

A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.

T Zimmermann-Belsing1, L Christensen, H S Hansen, J Kirkegaard, M Blichert-Toft, U Feldt-Rasmussen.   

Abstract

Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology most commonly affecting young females. The disease was first described in the thyroid gland in 1938. Our patient, a 27-year-old male with known sarcoidosis, was referred to the National University Hospital for acute symptoms of thyrotoxicosis (weight loss of 6 kg, tremor, thyroid enlargement, and tachycardia). Laboratory findings showed suppressed serum thyrotropin (TSH, <0.03 mU/L [0.5-4.20]), increased total thyroxine (T4) (223 nmol/L, [60-140]), and triiodothyronine (T3) (8.5 nmol/L, [1.5-2.7]). Furthermore, Tc-99m pertechnetate scintigraphy disclosed diffuse accumulation of the isotope confirming the diagnosis of Graves' disease. During the next 18 months of antithyroid treatment (thiamazole, Thycapzol) hyperthyroidism was difficult to control, the thyroid gland gradually enlarged, and surgery was recommended. Initially, the patient declined surgery but after an additional 18 months, he accepted surgery. During the 36-month period of antithyroid drug treatment TSH was suppressed (<0.01 mU/L) and T3 often elevated despite high doses of thiamazole. Total thyroidectomy was performed, and histologic examination of the removed thyroid tissue confirmed the diagnosis of Graves' disease and also the presence of sarcoid granuloma and metastatic papillary adenocarcinoma with spread to neck lymph nodes. Four months later, a modified radical neck dissection was performed with removal of neck lymph nodes followed by external radiation therapy (2 Gy x 32 fractions to the neck). The concomitant presence of sarcoidosis, papillary carcinoma, and Graves' disease in a thyroid gland, to our knowledge, has not previously been described in the literature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779143     DOI: 10.1089/thy.2000.10.275

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  Concomitant sarcoidosis and papillary thyroid cancer with severe hypercalcaemia as the main symptom.

Authors:  Mikael Groth Riis; Kasper Svendsen Juhl; Jens Meldgaard Bruun
Journal:  BMJ Case Rep       Date:  2018-06-08

2.  A case of Graves' disease developing with exacerbation of sarcoidosis.

Authors:  Shinya Makino; Chisako Yagi; Mariko Naka; Sachie Hirose; Masayoshi Fujiwara; Chiho Ohbayashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

3.  The sarcoid granuloma: 'epithelioid' or 'lymphocytic-epithelioid' granuloma?

Authors:  Zdravko Kosjerina; Bojan Zaric; Dejan Vuckovic; Dusan Lalosevic; Goran Djenadic; Bruno Murer
Journal:  Multidiscip Respir Med       Date:  2012-06-20

Review 4.  Sarcoidosis of the thyroid gland associated with hyperthyroidism: review of the literature and report of two peculiar cases.

Authors:  G Papi; F Briganti; F Artioli; A Cavazza; C Carapezzi; A Roggeri; C Baldoni; C Carani; V Chiarini; E Roti
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 5.467

5.  The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study.

Authors:  Vera Wenter; Nathalie L Albert; Freba Ahmaddy; Marcus Unterrainer; Julia Hornung; Harun Ilhan; Peter Bartenstein; Christine Spitzweg; Nikolaus Kneidinger; Andrei Todica
Journal:  BMC Cancer       Date:  2021-02-07       Impact factor: 4.430

6.  Resistant thyrotoxicosis: A case of sarcoidosis of thyroid.

Authors:  Uday Yanamandra; Narendra Kotwal; Anil Menon; Velu Nair
Journal:  Indian J Endocrinol Metab       Date:  2013-03

7.  Coexistence of sarcoidosis and metastatic lesions: A diagnostic and therapeutic dilemma.

Authors:  Christoph Spiekermann; Meike Kuhlencord; Sebastian Huss; Claudia Rudack; Daniel Weiss
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.